Absence of Epidermal Antibodies in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results
Background. Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and potentially life-threatening mucocutaneous blistering diseases that clinically can resemble autoimmune bullous diseases. Moreover, it has been shown that autoantibodies against epidermal proteins are present...
Saved in:
| Main Authors: | Gilles F. H. Diercks, Joost M. Meijer, Maria C. Bolling, Sonja M. H. J. Scholtens-Jaegers, Jeroen Bremer, Barbara Horvath |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Dermatology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2024/5504462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Jeanneth Elizabeth Jami Carrera, et al.
Published: (2024-11-01) -
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): an update
by: O. Mogole, et al.
Published: (2016-11-01) -
A review of the immunogenetics of Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Ayca Kocaaga, et al.
Published: (2025-09-01) -
Recent advances in the diagnosis and treatment of Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Yuko Watanabe, et al.
Published: (2025-07-01) -
METHOTREXATE-ASSOCIATED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: TWO CASE REPORTS
by: Yakup Unsal, et al.
Published: (2025-07-01)